B-type natriuretic peptide levels predict outcomes in infants undergoing cardiac surgery in a lesion-dependent fashion  by Amirnovin, Rambod et al.
Amirnovin et al Congenital Heart DiseaseB-type natriuretic peptide levels predict outcomes in infants
undergoing cardiac surgery in a lesion-dependent fashionRambod Amirnovin, MD,a,b Roberta L. Keller, MD,a Christina Herrera, BA,b Jong-Hau Hsu, MD,c
Sanjeev Datar, MD, PhD,a Tom R. Karl, MD,d Ian Adatia, MBChB,e Peter Oishi, MD,a,b and
Jeffrey R. Fineman, MDa,bFrom th
sity o
Medi
Servi
Depa
This re
Clini
Instit
HD04
the N
J.R.F
suppo
Hosp
Disclos
Receive
publi
Address
of Ca
1346
0022-52
Copyrig
http://dx
C
H
DObjective: B-type natriuretic peptide is used in the diagnosis, risk stratification, and management of adult pa-
tients with cardiac disease. However, its use in infants with congenital heart disease has been limited, particu-
larly in the perioperative period. Our objective was to determine the alterations in perioperative B-type
natriuretic peptide levels and their predictive value on postoperative outcomes, in infants undergoing congenital
heart surgery.
Methods: We prospectively enrolled 115 patients: 24 with univentricular heart disease undergoing a modified
Norwood procedure, 11 with d-transposition of the great arteries, 55 with hemodynamically important left-to-
right shunt, and 25 with tetralogy of Fallot undergoing primary repair. Clinical data and B-type natriuretic
peptide samples were collected before and 2, 12, and 24 hours after cardiopulmonary bypass. Univariate analysis
and multivariate linear regression analysis were performed.
Results: The perioperative B-type natriuretic peptide levels were lesion specific. Patients with d-transposition of
the great arteries and univentricular heart disease had high preoperative B-type natriuretic peptide levels that
decreased postoperatively, and thosewith hemodynamically important left-to-right shunts and tetralogy of Fallot
had lower preoperative levels that increased during the first 12 hours postoperatively. The patients with univen-
tricular heart diseasewith an adverse outcome had a significantly greater 24-hour B-type natriuretic peptide level
than those without (P<.05). Those with hemodynamically important left to right shunts and an adverse outcome
had a greater 12-hour B-type natriuretic peptide level than those without (P<.05). A 12-hour postoperative/
preoperative ratio greater than 45 was 100% sensitive and 82% specific for an adverse outcome in the patients
with tetralogy of Fallot.
Conclusions: The perioperative changes in B-type natriuretic peptide levels and their ability to predict outcomes
are lesion-specific. Characterization of these changes might be useful in caring for infants after congenital heart
surgery. (J Thorac Cardiovasc Surg 2013;145:1279-87)Surgical repair or palliation of congenital cardiac defects
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The Journal of Thoracic and Caroutcomes are often unpredictable. Neonates and infants
experience adverse events more often and have greater peri-
operative mortality than older children. Although risk-
adjustment scoring systems and various biomarkers have
been investigated, it remains difficult to identify individual
patients with an increased risk of a poor postoperative
outcome.1,2
B-type natriuretic peptide (BNP) is commonly used as
a biomarker for the diagnosis, risk stratification, and man-
agement of adult heart failure, but a similar use in neonates
and infants undergoing surgical repair or palliation of
congenital cardiac defects has not yet been established.3-7
However, several recent studies of this patient population
have found that perioperative BNP levels were predictive
of important clinical outcomes. These studies also
suggested that age and the specific cardiac defect type
might significantly influence the manner in which BNP
levels related to clinical outcomes. Thus, it appears that
the assay of BNP as a part of perioperative management
offers potential benefit. However, additional study is
necessary to determine how best to use the BNP
determinations across the spectrum of patients undergoingdiovascular Surgery c Volume 145, Number 5 1279
Abbreviations and Acronyms
AVdO2 ¼ arterial-venous oxygen saturation
difference
BNP ¼ B-type natriuretic peptide
CPB ¼ cardiopulmonary bypass
LCOS ¼ low cardiac output syndrome
LRS ¼ left to right shunt
TGA ¼ d-transposition of the great arteries
TOF ¼ tetralogy of Fallot
UVH ¼ univentricular heart
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Dsurgery for the repair or palliation of congenital cardiac
defects.8,9
Therefore, the objectives of the present study were to de-
termine and compare the perioperative BNP levels and the
potential predictive value of these levels for the postopera-
tive outcome in 2 groups of neonates and 2 groups of
infants, including 4 cardiac defects with distinct periopera-
tive physiologic features. We hypothesized that BNP levels
would be associated with clinical outcomes in an age- and
cardiac defect-dependent manner.METHODS
We conducted a prospective cohort study in the pediatric cardiac in-
tensive care unit at the University of California, San Francisco, Benioff
Children’s Hospital between June 2005 and October 2009. The eligible
patients were neonates and infants with congenital cardiac defects un-
dergoing surgical repair or palliation using cardiopulmonary bypass
(CPB). To eliminate some potentially confounding variables, patients
were excluded from the study if they weighed less than 2 kg, were older
than 12 months, or were less than 36 weeks postmenstrual age at
surgery.
We prospectively studied 115 neonates and infants. To compare single
ventricle and biventricular disease, neonates with univentricular heart dis-
ease (UVH), undergoing a modified Norwood procedure, were studied and
compared with neonates with d-transposition of the great arteries (TGA),
undergoing an arterial switch operation. Similarly, to assess the differences
related to preoperative pulmonary blood flow, infants with large left-to-
right shunts (LRSs), undergoing primary repair, were studied and com-
pared with infants with tetralogy of Fallot (TOF), undergoing primary
repair. In all 4 groups, systemic arterial plasma BNP determinations
were made before and 2, 12, and 24 hours after CPB.
The preoperative anesthesia management, intraoperative bypass
strategy, and subsequent pediatric cardiac intensive care unit manage-
ment followed standard institutional practices. The clinical team,
which was unaware of the BNP values, made all patient management
decisions. The study was conducted under approval of the University
of California, San Francisco, institutional review board. The patients’
parents or guardians provided written informed consent before
enrollment.
Patient Classification
We divided the patients into 4 groups according to the preoperative
echocardiographic findings and intraoperative verification by the surgeon:
group I (UVH) included neonates with single ventricle physiology under-
going palliation with a modified Norwood procedure, group II (TGA) in-
cluded neonates undergoing an arterial switch procedure for TGA; group1280 The Journal of Thoracic and Cardiovascular SurIII (LRS) included those with LRSs, including large ventricular septal de-
fects and balanced atrioventricular septal defects undergoing biventricular
repair; and group IV (TOF) included infants undergoing biventricular
repair of TOF.
Data Collection
Blood samples were obtained from an arterial catheter preoperatively
(before skin incision) and at 2, 12, and 24 hours after CPB. The BNP levels
were measured using a commercially available fluorescence immunoassay
(Triage Meter Plus; Biosite Diagnostic, San Diego, Calif). The measurable
range of BNP on this device is 5 to 5000 pg/mL. The coefficient of variation
for the assay is 9.2% to 11.4%.
Clinical and biochemical data were collected prospectively at each sam-
pling point and daily thereafter. The clinical data collected included patient
demographics, CPB duration, aortic crossclamp duration, inotrope dose,
mean systemic arterial pressure, central venous pressure, heart rate, arterial
saturation using pulse oximetry, cerebral oxygen saturation using near in-
frared spectroscopy, intensive care unit duration, hospital stay, and me-
chanical ventilation duration. The biochemical data collected included
hematocrit, arterial and venous blood gases, serum lactate, blood urea
nitrogen, and creatinine.
Outcome Measures
The primary endpoint was the occurrence of a major poor postoperative
outcome within 6 months of surgery, defined as death, the need for an un-
planned invasive catheter-based or surgical intervention, the need for extra-
corporeal life support (ECLS) after surgery, or the need for cardiac
transplantation.
The secondary endpoints included the mechanical ventilation duration,
duration of hospitalization, and development of low cardiac output syn-
drome (LCOS) within 48 hours after surgery. The definition of LCOS
was derived from criteria published by Hoffman and colleagues,10 that in-
cluded a combination of changes in clinical signs and laboratory indicators.
The criteria included tachycardia, oliguria, poor perfusion, cardiac arrest,
or metabolic acidosis and the need for interventions aimed at augmenting
cardiac output, such as increased pharmacologic support relative to base-
line and cardiac pacing.
Calculations
Inotrope usewas quantified by a score adapted fromWernovsky and col-
leagues.11 The score was calculated from the level of inotropic support the
patients were receiving (in mg/kg/min), at each sampling point according to
the following equation: dopamine þ dobutamine þ [(epinephrine þ
norepinephrine) 3 100]þ (milrinone 3 20). The arterial-venous oxygen
saturation difference (AVdO2) was calculated as the co-oximetric arterial
oxyhemoglobin saturation minus the central venous oxyhemoglobin
saturation.
Statistical Analysis
Differences in the continuous variables between groups were tested
with the Student t test for normally distributed variables and the Mann-
Whitney U test for non-normally distributed variables. Differences in the
categorical variables between groups were tested with Fisher’s exact test.
Contingency tables were formulated to determine the sensitivity and spec-
ificity of the BNP measurements. Correlations between variables were per-
formed using the Spearman rank correlation method. The predictive value
of BNP for the primary and secondary outcomes was tested for potential
demographic and physiologic confounders with multivariate regression
analysis when adequate outcomes were available. Changes in BNP over
time were compared by repeated measures analysis of variance. Statistical
analyses were performed with the use of Prism, version 4.0 (GraphPad
Software, Inc, San Diego, Calif) and Stata, version 11.0 (StataCorp,
College Station, Tex).gery c May 2013
TABLE 1. Preoperative demographics
Variable
Neonates Infants
Group I
(UVH)
Group II
(TGA) P value*
Group III
(LRS)
Group IV
(TOF) P value*
Patients 24 11 55 25
Age 9  8 d 10  9 d .87 10  2 mo 4  3 mo .02
Weight (kg) 3.3  0.4 3.5  0.4 .26 6.4  1.4 5.2  1.5 .09
Males (n) 10 (42%) 10 (91%) <.01 28 (50%) 16 (64%) .28
Surgery type Norwoody Arterial switch Primary repair Primary repair
Cardiac lesion 15 HLHS; 3 Shone’s complex;
2 IAA, HAA; 2 DORV, HRV,
HAA; 2 tricuspid atresia,
TGA, HRV, HAA
11 d-TGA 40 VSD 15 AVSD 25 TOF
Preoperative data
HR (min1) 151  16 147  25 .6 134  20 135  18 .8
MAP (mm Hg) 49  7 48  5 .6 62  12 61  15 .7
Pulse oximetry
(% saturation)
91  6 89  6 .3 98  0.4 94  1 <.01
Mechanical ventilation 16 (67%) 10 (91%) .4 4 (7%) 4 (30%) .4
PGE1 21 (88%) 11 (100%) .5 0 (0%) 1 (4%) .4
BUN (mg/dL) 15  8 10  6 .2 11  5 8  5 .04
Blood creatinine (mg/dL) 0.5  0.2 0.6  0.1 .2 0.4  0.1 0.4  0.1 .2
Data presented as mean  SD or number (%). UVH, Univentricular heart; TGA, d-transposition of great arteries; LRS, left to right shunt; TOF, tetralogy of Fallot; HLHS, hy-
poplastic left heart syndrome; IAA, interruption of aorta; HAA, hypoplastic aortic arch; DORV, double outlet right ventricle; HRV, hypoplastic right ventricle; VSD, ventricular
septal defect; AVSD, atrioventricular septal defect; HR, heart rate; MAP, mean arterial pressure; PGE1, prostaglandin E1; BUN, blood urea nitrogen. *P values for comparisons
between groups I and II (neonates) and between groups III and IV (infants). yOf 24 patients, 22 underwent right ventricle-pulmonary artery conduit, 1 modified Blalock-Taussig
shunt, and 1 an aortopulmonary shunt.
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DRESULTS
Subjects and Outcomes by Patient Group
A total of 115 neonates and infants were enrolled in the
study, with 24 patients in group I (UVH), 11 in group II
(TGA), 55 in group III (LRS), and 25 in group IV (TOF).
The patients’ preoperative characteristics are listed in
Table 1. The neonates in groups I and II ranged in age
from 1 to 35 days, and the infants in groups III and IV
ranged in age from 1 to 12 months.
The patients’ intraoperative and postoperative character-
istics are listed in Table 2, with comparisons between the 2
neonatal and 2 infant groups presented. In the neonates, the
CPB times were similar; however, the UVH group hadTABLE 2. Intraoperative and postoperative characteristics
Group I
(UVH, n ¼ 24)
Group II
(TGA, n ¼ 11
CPB time (min) 127  25 122  16
Crossclamp time (min) 47  12 59  12
12-h Inotrope score 13  6 12  6
12-h Serum lactate (mmol/L) 4.5  2.3 2.8  1.7
Hospital length of stay (d) 31 (24-42) 17 (14-23)
Mechanical ventilation duration (d) 6 (3-12) 3 (2-5)
LCOS 19 (79%) 6 (55%)
ECLS required 4 (17%) 0 (0%)
Major poor outcomes 4 (17%) 0 (0%)
Data presented as mean  SD, number (%), or median (interquartile range). UVH, Unive
tetralogy of Fallot;CPB, cardiopulmonary bypass; ECLS, extracorporeal life support; LCOS
groups III and IV (infants).
The Journal of Thoracic and Carshorter crossclamp times than the TGA group (47  12
vs 59  12 minutes, P<.01). The 12-hour inotrope scores
were similar; however, patients in the UVH group had
greater 12-hour serum lactate levels, longer hospital stays,
and a longer duration of postoperative mechanical ventila-
tion than the TGA group. The incidence of LCOS and the
need for ECLS were greater in the UVH patients, although
these differences did not reach statistical significance. No
neonates had a major poor outcome in the TGA group
compared with 4 patients with a major poor outcome in
the UVH group. All these newborns were supported
with ECLS and died within the index hospitalization
(Table 3).) P value*
Group III
(LRS, n ¼ 55)
Group IV
(TOF, n ¼ 25) P value*
.31 78  33 105  43 <.01
<.01 52  20 55  25 .98
.72 7  6 7  6 .88
.03 1.3  0.8 1.4  0.7 .4
<.01 6 (5-9) 8 (6-11) .09
.03 0.8 (0.3-1) 1.1 (0.7-3) <.01
.13 10 (18%) 9 (36%) .08
.15 0 (0%) 1 (4%) .81
.15 2 (3%) 3 (12%) .17
ntricular heart; TGA, d-transposition of great arteries; LRS, left to right shunt; TOF,
, low cardiac output status. *P values between groups I and II (neonates) and between
diovascular Surgery c Volume 145, Number 5 1281
TABLE 3. Summary of patients with major poor outcome
Group Pt. no., diagnosis, and procedure
Major poor outcome
(within 6 mo)
Postoperative interval
to outcome (d)
I (UVH) 1, HLHS after Norwood and RVPA shunt ECLS, death 3, 6
2, HLHS after Norwood and RVPA shunt ECLS, death 2, 24
3, Schone’s complex after Norwood
and RVPA shunt
ECLS, death 15, 36
4, HLHS after Norwood and BTS ECLS, death 4, 25
III (LRS) 5, AVSD after 2 patch repair Death 41
6, AVSD after 2 patch repair Mitral valve repair 21
IV (TOF) 7, TOF after RVPA conduit, VSD closure ECLS, death 1, 10
8, TOF after TAP, VSD closure VSD patch leak repair 8
9, TOF after TAP, VSD closure Outflow tract revision 35
Pt. no., Patient number; UVH, univentricular heart; HLHS, hypoplastic left heart syndrome; RVPA, right ventricle to pulmonary artery; ECLS, extracorporeal life support; BTS,
Blalock-Taussig shunt; LRS, left to right shunt; AVSD, atrioventricular septal defect; TOF, tetralogy of Fallot; TAP, transannular patch; VSD, ventricular septal defect.
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DIn the infant populations, the CPB times were longer in
the TOF group than in the LRS group (105  43 vs 78 
33 minutes, P< .01). The 12-hour lactate and inotrope
scores were similar between the TOF and LRS groups.
The incidence of LCOS and hospital length of stay were
greater in the TOF group, but these differences did not reach
statistical significance. The patients in the TOF group had
longer durations of mechanical ventilation (P<.01). There
were 3 patients with a major poor outcome in the TOF
group, including 1 death and 2 unplanned interventions.
The patient who died was also supported by ECLS. In the
LRS group, there were 2 major poor outcomes: 1 death
and 1 unplanned intervention. All major poor outcomes in
the infant groups occurred during the index hospitalization
(Table 3).Perioperative BNP Levels
The BNP levels preoperatively and at 2, 12, and 24 hours
postoperatively for all 4 groups are shown in Figure 1. AsFIGURE 1. Comparison of B-type natriuretic peptide (BNP) before and
after cardiopulmonary bypass in all 4 diagnostic groups. NORW, Norwood
procedure (univentricular heart); TGA, d-transposition of the great arteries;
LRS, left to right shunt; TOF, tetralogy of Fallot. Data presented as mean
SD. Analysis of variance analysis within all groups, P<.01.
1282 The Journal of Thoracic and Cardiovascular Surexpected, the preoperative BNP levels were greater in the
neonates than in the infants (1583  1140 vs 93  135
pg/mL, P < .01). In both neonatal groups (UVH and
TGA), the BNP levels were greatest in the preoperative pe-
riod, decreasing significantly by 24 hours after CPB (re-
peated measures analysis of variance, P < .01 for both
groups). In contrast, the BNP levels were lowest in the
preoperative period in the infant groups (LRS and TOF).
In these groups, the BNP levels peaked at the 12-hour point
(P<.01 compared with the preoperative levels).Preoperative BNP Levels and Outcomes
Within each group, no association was found between
the preoperative BNP levels and any of the demographics
or postoperative primary or secondary outcomes (data not
shown). In the LRS group, the preoperative BNP levels cor-
related with all postoperative BNP levels, although most
strongly with the 2-hour levels (2 hours, rho ¼ 0.78,
P< .001; 12 hours, rho ¼ 0.31, P ¼ .01; and 24 hours,
rho ¼ 0.40, P<.01). In the other groups, the preoperative
BNP levels correlated with the postoperative BNP levels
only at 2 hours (UVH, rho ¼ 0.65, P < .001; TGA,
rho ¼ 0.72, P ¼ .01; TOF, rho ¼ 0.64, P<.001).Postoperative BNP Levels and Major Poor Outcome
In the UVH group, the 12- and 24-hour BNP levels
were greater in patients with a major poor outcome than
in those with a good outcome (12 hours, 1776  329 vs
1159  204 pg/mL, P ¼ .04; 24 hours, 1188  88 vs
593  88 pg/mL, P< .01; Figure 2). The perioperative
characteristics of the patients in the UVH group stratified
by outcome are summarized in Table 4. Neonates with
a poor outcome had greater 12-hour inotrope scores and
serum lactate levels, although these differences were not
significant.
The 12- and 24-hour BNP levels were greater in patients
with amajor poor outcome than in thosewith a good outcome
in the LRS group (12 hours, 1215 375 vs 492 62 pg/mL,gery c May 2013
FIGURE 2. Group I (univentricular heart [UVH]). Comparisons of changes in, Left, absolute B-type natriuretic peptide (BNP) levels and, Right, postop-
erative/preoperative (post/pre) BNP ratios over time between patients with good outcomes (n¼ 20) and patients with poor outcomes (n¼ 4). Both absolute
and ratios of BNP were greater at 12 and 24 hours after cardiopulmonary bypass in poor outcome group. Data presented as mean  SD. *P<.05 vs good
outcome (Student t test).
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DP¼ .04; 24 hours, 822 44 vs 375 28 pg/mL,P¼ .02) and
TOF group (12 hours, 476 53 vs 368 40 pg/mL, P¼ .04;
24 hours, 378  92 vs 302 41 pg/mL, P ¼ .04). Figures 3
and 4 demonstrate the BNP levels stratified by outcome
for the infant groups. The characteristics of the patients in
the LRS and TOF groups stratified by outcome are
summarized in Table 5.TABLE 4. Characteristics of group I (UVH) patients stratified by
primary outcome
Group I (UVH, n ¼ 24)
Good
outcome
Poor
outcome P value
Patient number (%) 20 (83%) 4 (17%)
Age (d) 10  8 6  3 .4
Weight (kg) 3.4  0.5 3.2  0.4 .5
CPB time (min) 128  26 118  21 .5
Crossclamp time (min) 47  13 46  9 .9
12-h Post-CPB characteristics
HR (min1) 165  12 159  15 .4
MAP (mm Hg) 54  9 50  7 .4
Inotrope score 11.5  5.2* 21  8* .06
Serum lactate (mmol/L) 4.1  2.1 6.5  2.3 .06
BUN (mg/dL) 16  7 17  8 .9
Blood creatinine (mg/dL) 0.68  0.2 0.9  0.4 .2
Secondary outcome characteristics
Hospital length of stay (d) 31 (24-39) 43 (22-145) .5
Mechanical ventilation
duration (d)
6 (3-12) 13 (6-52) .4
LCOS 15 (75%) 4 (100%) .54
Data presented as mean  SD, number (%), or median (interquartile range). No pa-
tients in group II (d-transposition of great arteries) had 6-month poor outcomes.UVH,
Univentricular heart; CPB, cardiopulmonary bypass; HR, heart rate; MAP, mean ar-
terial pressure; BUN, blood urea nitrogen; LCOS, low cardiac output syndrome.
*Good outcome, n ¼ 11; poor outcome, n ¼ 2.
The Journal of Thoracic and CarPerioperative BNP Change and Primary and
Secondary Outcomes
Because absolute BNP levels appear to be age and lesion
specific, and preoperative BNP levels are variable, we also
examined the relationship between the change in BNP dur-
ing the first 24 hours after surgery and both primary and sec-
ondary outcomes. To accomplish this, we standardized the
patients’ postoperative BNP levels to their preoperative
levels, expressed as a postoperative/preoperative (post/
pre) BNP ratio. The right panels of Figures 2 through 4
show the post/pre BNP ratios at each point for the
patients with good and poor postoperative outcomes for
the UVH, LRS, and TOF groups, respectively.
In the UVH group, the post/pre BNP ratios at 12 and 24
hours were greater in patients with a major poor outcome
than in those with a good outcome (12 hours, 1.84  0.34
vs 1.07  0.21, P ¼ .04; 24 hours, 1.16  0.17 vs 0.58 
0.10, P ¼ .03). Receiver operating characteristic curves in-
dicated that a 12-hour post/pre BNP ratio greater than 1.0
was 63% sensitive and 81% specific for a poor postopera-
tive outcome (area under the curve 0.72). In the UVH group,
the post/pre BNP ratios at 12 and 24 hours were greater in
patients with a mechanical ventilation duration of 7 days
or longer (n ¼ 10) compared with those with less than 7
days (12-hour ratio, 2.28  0.3 vs 0.65  0.8, P ¼ .03,
24-hour ratio, 1.32  0.4 vs 0.38  0.5, P ¼ .03). The
post/pre BNP ratios at 12 hours were also greater in patients
with a hospital length of stay of 30 days or longer (n ¼ 12)
than in those with a length of stay shorter than 30 days (12-
hour ratio, 2.0  0.4 vs 0.65  0.2, P ¼ .02). The absolute
BNP levels were not different between patients with these
secondary outcomes at any point, indicating that the change
in BNP levels was a better predictor of these outcomes than
the absolute levels. No differences were found in the BNPdiovascular Surgery c Volume 145, Number 5 1283
FIGURE 3. Group III (left to right shunt [LRS]). Comparisons of changes in, Left, absolute B-type natriuretic peptide (BNP) levels and, Right, postop-
erative/preoperative (post/pre) BNP ratios over time between patients with good outcomes (n¼ 53) and patients with poor outcomes (n¼ 2). Both absolute
and ratios of BNP were greater at 12 and 24 hours after cardiopulmonary bypass in poor outcome group. Data presented as mean  SD. *P<.05 vs good
outcome (Student t test).
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outcomes in the TGA group (n¼ 2 and n¼ 1 for prolonged
ventilation and hospitalization, respectively).
In the LRS and TOF groups, the 12- and 24-hour post/pre
BNP ratios were greater in patients with poor outcomes than
in those with good outcomes (Figures 3 and 4). In the TOF
group, all 3 patients with a major poor outcome had a 12-
hour post/pre BNP ratio greater than 45, and all patients
with a good outcome had a 12-hour post/pre BNP ratio
less than 10 (mean 12-hour post/pre BNP ratio, 29). In the
infant populations, no associations were seen between the
BNP ratios and our secondary outcomes.
Serum Lactate Levels
We examined the relationship between the serum lactate
level at each sampling point and outcomes for each group,FIGURE 4. Group IV (tetralogy of Fallot [TOF]). Comparisons of changes in
ative/preoperative (post/pre) BNP ratios over time between patients with good o
values and ratios of BNP were greater at 12 and 24 hours after cardiopulmonary
good outcome (Student t test).
1284 The Journal of Thoracic and Cardiovascular Surgiven the common use of lactate levels to detect LCOS in
these patients. No significant association was seen between
the serum lactate levels and the occurrence of major poor
outcomes or our secondary outcomes of prolonged mechan-
ical ventilation and prolonged hospitalization. In addition,
the postoperative/preoperative serum lactate ratios were
not associated with our primary or secondary outcomes
(data not shown).
Other Variables
Physiologic parameters such as heart rate, mean arterial
pressure, central venous pressure, cerebral oximetry, and
pulse oximetry were not associated with our primary or sec-
ondary outcomes. In all groups, the changes in these param-
eters over time between those with a major poor outcome
versus a good outcome were also not significant using, left, absolute B-type natriuretic peptide (BNP) levels and, right, postoper-
utcomes (n ¼ 22) and patients with poor outcomes (n ¼ 3). Both absolute
bypass in poor outcome group. Data presented as mean  SD. *P<.05 vs
gery c May 2013
TABLE 5. Characteristics of groups III and IV stratified by primary outcome
Group III (LRS; n ¼ 55) Group IV (TOF; n ¼ 25)
Good outcomes Poor outcomes P value Good outcomes Poor outcomes P value
Patients 53 (96%) 2 (4%) 22 (88%) 3 (12%)
Age (mo) 10.2  2.9 4.8  3.7 .3 4.6  2.5 2.2  1.8 .04
Weight (kg) 6.7  3.5 4.3  1.0 .1 5.7  1.2 3.8  1.6 <.01
CPB time (min) 73  29 118  37 <.01 100  37 120  57 .3
Crossclamp time (min) 50  19 70  23 .02 59  25 40  24 .1
12-h Post-CPB characteristics
HR (min1) 125  23 138  19 .2 136  19 138  15 .8
MAP (mm Hg) 66  8 52  8 <.01 61  10 62  14 .8
Inotrope score 6.5  5.6 8.8  7.6 .4 6.5  4.9 8.7  9.1 .4
Serum lactate (mmol/L) 1.2  0.7 1.6  1.3 .4 1.4  0.7 1.5  0.5 .8
BUN (mg/dL) 12.9  5.9 15.2  6.0 .4 11.5  4.9 13.3  4.2 .5
Blood creatinine (mg/dL) 0.44  0.1 0.56  0.21 .04 0.47  0.14 0.57  0.15 .3
Secondary outcome characteristics
Hospital length of stay (d) 6 (5-8) 15 (10-21) <.01 8 (6-10) 11 (5-36) .5
Mechanical ventilation duration (d) 0.8 (0.5-1.0) 5.0 (0.5-6.0) .3 1.0 (0.7-2.9) 1.3 (0.7-36) .6
LCOS 9 (19%) 1 (50%) .06 7 (28%) 2 (66%) .07
Data presented as mean  SD, number (%), or median (interquartile range). CPB, Cardiopulmonary bypass; HR, heart rate; MAP, mean arterial pressure; BUN, blood urea
nitrogen; LCOS, low cardiac output syndrome; LRS, left to right shunt; TOF, tetralogy of Fallot.
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controlled for other variables, such as renal function, patient
age, CPB time, weight, and other demographic and physio-
logic parameters collected, the associations between BNP
and the primary and secondary outcomes remained inde-
pendent on multivariate analysis. This suggests that BNP
is a simple, single predictor that might be a useful adjunct
to more complex risk assessments that include factors
such as young age, low weight, and CPB time, for example.DISCUSSION
These data suggest that BNP is a valuable biomarker for
prognostication and risk stratification in neonates and in-
fants undergoing repair or palliation of cardiac defects.
However, the present findings indicate that the interpreta-
tion of perioperative BNP levels with respect to outcomes
will differ according to patient age and perioperative phys-
iologic features (eg, type of defect and surgical procedure).
Neonates undergoing a modified Norwood procedure or ar-
terial switch procedure had high preoperative BNP levels
that decreased during the first 24 hours after CPB. In con-
trast, infants undergoing primary repair of a VSD, atrioven-
tricular septal defect, or TOF had lower preoperative BNP
levels that increased after CPB, reaching a peak at 12 hours.
Furthermore, deviations from the aggregate pattern of
change were associated with a 6-month composite poor out-
come. Specifically, in neonates undergoing a modified Nor-
wood procedure, a failure of BNP levels to decrease
postoperatively was associated with a poor outcome; how-
ever, in infants, an exaggerated postoperative increase in
BNP was associated with a poor outcome. Although our
study did not determine possible etiologies for theThe Journal of Thoracic and Cardifferences in the perioperative BNP changes, it highlights
the utility of understanding such age- and lesion-dependent
differences.
In contrast, absolute BNP levels were not associated with
outcomes except in the UVH group. Therefore, our results
are consistent with an expanding experience indicating
that a single cutoff value is unlikely to provide value across
the varied spectrum of pediatric patients undergoing surgery
for congenital heart disease. However, these data do suggest
that perioperative patterns of change in BNP levels can be
established for groups of patients classified by age and peri-
operative physiologic features. Moreover, deviations from
these patterns of change provide valuable clinical insights
that are not reproduced by currently available biomarkers
or known risk factors (eg, CPB time, age). The precise rea-
son the BNP levels were independently associated with our
primary and secondary outcomes in these patients even after
multivariate analysis is unclear. Some theories include vol-
ume load on the ventricle not predicted by central venous
pressure values, ventricular wall stress not suspected during
adequate oxygen delivery (ie, normal lactates or AVdO2
values), or residual lesions not routinely noted in the inten-
sive care unit until a later echocardiogram or catheteriza-
tion. Additional studies are required to better determine
the mechanisms of BNP regulation, including its expression
and clearance, to answer these important questions.
In agreement with previous studies, we found wide vari-
ability in BNP levels (Figure 1). These previous studies sug-
gested that this variability is influenced in part by age, the
type of cardiac defect, and exposure to CPB.12-16 Our
study of neonatal patients has demonstrated that even age-
controlled patients have significant preoperative variability
in their BNP levels. This could explain the poor associationdiovascular Surgery c Volume 145, Number 5 1285
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lights the utility of post/pre BNP ratios. It also demonstrates
that BNP levels are not dictated by age alone but, rather, by
a complex interplay among a patient’s age, physiologic fea-
tures, and anatomy.
Only limited data are available relating perioperativeBNP
levels to outcomes in any pediatric age group undergoing
cardiac surgery for congenital heart disease. An initial study
of 51 infants and children with biventricular cardiac defects
found that BNP levels increased after surgery, peaking at 12
hours, and that the 12-hour level was associated indepen-
dently with the need for mechanical ventilation beyond 48
hours and the development of LCOS.17 Other studies have
examined N terminal-proBNP levels in infants and children
undergoing cardiac surgery.18-20 One study demonstrated
a peak elevation at 24 hours postoperatively that correlated
with postoperative outcomes, including the duration of
mechanical ventilation, CPB length, and inotropic score.20
Virtually all the studies of a pediatric cardiac surgical popu-
lation have found that BNP levels increased postoperatively
in infants, consistent with the findings in the infants in the
present study.14,17,21,22 We also found that these elevations
are predictive of postoperative outcomes.
In contrast to this established pattern in infants, the neo-
nates with good outcomes in our study demonstrated a de-
crease in BNP levels after surgery. No neonate whose
BNP level decreased postoperatively relative to their preop-
erative baseline had a poor postoperative outcome. In con-
trast, an increase in BNP greater than baseline after surgery
was associated with LCOS, a longer duration of mechanical
ventilation, and a 6-month composite of poor outcome. A
previous study from our institution demonstrated similar
findings in 31 neonates with a variety of cardiac defects un-
dergoing repair.23 In contrast to these studies, Niedner and
colleagues24 studied 102 neonates and non-neonatal con-
trols and found that the BNP levels increased after surgery,
peaking at 12 hours. The reasons for the differences be-
tween that study and our previous and present investigations
might relate in part to differences in the lesions of the co-
horts, including single and biventricular physiologic types.
This highlights the importance of stratification of BNP
changes by the specific lesion, instead of combining co-
horts, given the variability seen within lesion types.
In the present study, we compared 2 different populations
of neonates, those with single ventricle physiologic features
and those with TGA; both groups demonstrated a decrease
in postoperative BNP levels. Cannesson and colleagues25
measured perioperative BNP levels in 30 neonates undergo-
ing an arterial switch operation for TGA. In contrast to our
findings in the present, and a previous, study,23 the BNP
levels increased during the first 48 hours postoperatively
in their patient population. However, similar to our studies,
these levels were predictive of important postoperative out-
comes. The reasons for the differences in the pattern of1286 The Journal of Thoracic and Cardiovascular Surpostoperative BNP changes between these studies are un-
clear, particularly because the populations were similar
with respect to age and cardiac defect. These data suggest
that although particular patterns of BNP change within an
age and lesion might be predictive of postoperative out-
comes, the specific patterns that are predictive might be in-
stitution specific. Additional studies are warranted to
address this important disparity.
To date, the 2 most commonly used biomarkers to monitor
patients after congenital cardiac surgery are the AVdO2 and
serum lactate.1,26-28 The AVdO2 is a relatively reliable
indicator of the balance between oxygen delivery and
oxygen consumption and, thus, has been used successfully
to guide postoperative therapies.26 Several studies of serum
lactate have found that lactate, and its rate of change in the
postoperative period, predicted the outcome, including mor-
tality.1,27 However, these findings have not been reproduced
by other larger studies, and the precise lactate levels that were
predictive varied considerably, obviating a standardized
use of lactate as a prognostic biomarker.1,27,28 However,
because acute management decisions are aimed at
normalizing the venous oxyhemoglobin saturation and
lactate levels, it is likely that only persistently abnormal
values refractory to treatment will be predictive of an
adverse event in the short term. Therefore, it was not
surprising that serum lactate levels and postoperative
changes in serum lactate failed to predict postoperative
outcomes in the present study. However, the data were
insufficient to analyze the utility of AVdO2 in our study.
Thus, in our study, the postoperative change in BNP was
unique in its ability to predict outcomes. However, these
results might reflect that clinicians were unaware of the
BNP levels and thus were unable to knowingly modify the
factors contributing to the elevation in BNP.
Although the present study is the largest study of perio-
perative BNP levels in neonates and infants undergoing sur-
gery for congenital cardiac defects reported to date, its
primary limitation related to the limited number of patients
with outcomes of interest. For example, the TGA group had
no poor outcomes, and the other 3 groups had 2 to 4 patients
with poor outcomes. In addition, several important congen-
ital heart defects were not included in our study. Thus,
larger studies are needed to precisely define the role of
BNP in the management of congenital heart disease in neo-
nates and infants.
These data suggest that additional age- and lesion-
specific characterizations of perioperative BNP levels in
neonatal and pediatric patients with congenital heart disease
could lead to the establishment of BNP as an important
biomarker to predict both short- and long-term clinical
outcomes.
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